Clinical trial
Reoxygenation After Cardiac Arrest II (REOX II Study)
NCT02698826 is registered in ClinicalTrials.gov with The Cooper Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reoxygenation After Cardiac Arrest II (REOX II Study)
- Lead sponsor
- The Cooper Health System
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 30, 2016
- Completion date
- October 31, 2018
- Enrollment
- 16 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac arrest